For 1 mg: 1 / 5 = 0.2 mL = 20 units
Clem B, Telang S, Clem A, Yalcin A, Meier J, Simmons A et al
The headline results, as released in the Eli Lilly investor communication and aligned with the study design paper by Giblin and colleagues published in Diabetes, Obesity and Metabolism in 2026, are unusually strong for a Phase 3 obesity trial: Retatrutide 12 mg: mean body-weight reduction of 28.7 percent, roughly 32.3 kg (about 71.2 lbs) from baseline
If you are interested in compounded medications, please let your doctor know so that they decide if this is an appropriate treatment and explain how to give the injections
Use is restricted to qualified personnel in scientific research environments.